[1] |
LI Yingfen, HAN Lei.
Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198.
|
[2] |
LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong.
One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212.
|
[3] |
ZANG Tianying, LIU Bingyang, TANG Xiaojun.
Differentiation of vancomycin induced anaphylactoid and anaphylactic reactions
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(9): 1078-1080.
|
[4] |
CHEN Chao, ZHU Lan, LIU Lihong, HAN Jiayin, ZHU Yan.
Characteristics of Psoralea corylifolia induced liver injury
[J]. Chinese Journal of Pharmacovigilance, 2023, 20(4): 449-453.
|
[5] |
GENG Kexin, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian, SA Rina, JIANG Hao, ZOU Lina.
Safety of traditional Chinese medicine among lactating women and pharmacovigilance
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(8): 908-912.
|
[6] |
SUN Bao, BAI Yanning, ZHANG Yuanyuan, QIAO Yi, YANG Zhifu, WANG Jingwen, WEN Aidong.
Literature review of eosinophilic pneumonia induced by daptomycin
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(7): 757-761.
|
[7] |
LIU Chun, WANG Jucai, HUANG Yuchang, YE Xiaoqing, ZHAO Yingshu, ZHAN Meimei, WANG Chen.
Allergic test of azithromycin for injection in guinea pigs in non-clinical safety evaluation
[J]. Chinese Journal of Pharmacovigilance, 2022, 19(11): 1161-1164.
|
[8] |
YU Yi, HUANG Qianqian, XIAO Aili.
Analysis of Safety Risks of Ginkgo Biloba Tablets and Other Oral Preparations
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 678-682.
|
[9] |
ZHAO Zeqing, WANG Rui, YU Panpan, QIAO Pingping.
Literature Analysis of Adverse Drug Reactions Induced by Olanzapine
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 260-264.
|
[10] |
MAO Min, LIAO Mingyan, MAO Jian.
One Case of Anaphylaxis Induced by Peg-containing Cyclosporine Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(3): 274-276.
|
[11] |
YU Yi, WANG Hui, LIU Hongliang, WANG Chunting.
Analysis and Consideration on Risk of Sodium Aescinate for Injection
[J]. Chinese Journal of Pharmacovigilance, 2021, 18(2): 174-177.
|
[12] |
XU Wanyi, CUI Xiangli.
Literature Analysis of 45 Cases of Drug-induced Hyperuricemia
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 574-577.
|
[13] |
LIU Hongming, WANG Jian.
Literature Analysis of 52 Cases of Adverse Drug Reactions Induced by Escitalopram
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 578-582.
|
[14] |
YANG Lei, WANG Fengling, WU Jingwei, LI Jun.
Literature Analysis of Levofloxacin-induced Delirium
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(9): 631-635.
|
[15] |
CAI Jun, LI Huixin, LIU Mengying, YAO Yao, GE Weihong.
Safe Use of Lopinavir/Ritonavir for COVID-19 Based on Literature Analysis of Adverse Reactions
[J]. Chinese Journal of Pharmacovigilance, 2020, 17(6): 326-331.
|